No Data
No Data
Chemicals Maker Chemours Rises 10% After Naming Google Exec to Board
Goldman Sachs Maintains The Chemours(CC.US) With Hold Rating, Cuts Target Price to $21
Chemours Price Target Cut to $21.00/Share From $24.00 by Goldman Sachs
Chemours Is Maintained at Neutral by Goldman Sachs
Express News | Chemours Co - Board Increases Size From Ten to Eleven Members
Express News | Chemours Appoints Google Executive Joseph Kava to Its Board of Directors